Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-214-4 | CAS number: 21109-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
Na2S inhibited cytochrome oxidase and carbonic anhydrase prepared from brains of male rats in a concentration-dependent manner. Extensive disruption of respiratory and related mitochondrial functions was determined in homogenates of synaptosomes prepared from brains of CDI mice treated i.p. with Na2S.
Treatment of male Wistar rats with 11.7 mg/kg Na2S i.p. caused a partial inhibition of GABA and dopamine uptake, and it strongly inhibited veratridine-dependent release of these neurotransmitters and reduced veratridine-dependent changes in the trans-membrane potential in synaptosomes isolated from the hemispheres. However, single doses of Na2S (80-200 mg/kg) administered i.p. to rats indicated that very high doses are incapable of producing cerebral necrosis by a direct histotoxic effect.
Inhalation of hydrogen sulfide resulted in a marked, but reversible, decrease in the incorporation of leucine in the cerebral protein and myelin accompanied by a decreased activity of lysosomal acid proteinase after inhalation exposure of adult female mice at 100 ppm H2S for 2 h.
After repeated inhalation exposure of male rats (5 d, 3h/d) to low levels of H2S, the total power of hippocampal EEG theta activity increased in a concentration-dependent manner in both dentate gyrus and CA1 region that required two weeks for a complete recovery. Neocortical EEG and LIA (Large Amplitude Irregular Activity) were unaffected following exposure to 100 ppm H2S.
Determination of serotonin and norepinephrine levels in developing rat cerebellum and frontal cortex of pups from rats exposed for 7 h/d (GD 5 until PND 21) suggested that alterations of monoamine levels induced by H2S may produce long-lasting neurochemical changes in the CNS.
Short-term exposure of adult male rat to H2S for 3 h/d for 5 d significantly reduced motor activity, water maze performance, and body temperature following exposure to H2S concentrations ≥ 80 ppm, but did not affect regional brain catecholamine concentrations.
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
READ ACROSS CONCEPT
Valid toxicological data on neurotoxicity for barium sulfide from animal studies are not available. Therefore, because of the lack of appropriate experimental data, read-across from studies with H2S and BaCl2is proposed based on the following reasoning:
Read-across to H2S:
The readily water-soluble compound barium sulfide will initially dissociate upon dissolution in water and/or relevant physiological media into barium and sulfide ions.
However, sulfide anions will react with water in a pH-dependant reverse dissociation to form hydrogensulfide anions (HS-) or H2S, respectively, according to the following equation:
H2S ↔ H+ + HS- ↔ 2H+ + S2-
The dissociation behaviour is presented in the Hägg graph reported under IUCLID section 5.1.2 Hydrolysis.
The pKa values for the first and second dissociation steps of H2S are 7.0 and 12.9 (for details, refer to the IUCLID section on dissociation constant), respectively. Therefore, at neutral physiological pH values, hydrogen sulfide in the non-dissociated form (H2S) and the hydrogen sulfide anion (HS-) will be present in almost equimolar proportion, whereas only very small amounts of the sulfide anion (S2-) will be present. Conversely, at gastric pH (pH 1-2), non-dissociated H2S will be the predominant species.
In conclusion, under physiological conditions, inorganic sulfides or hydrogensulfides as well as H2S will dissociate to the respective species relevant to the pH of the physiological medium, irrespective of the nature of the “sulfide”, which is why read-across between these substances and H2S is considered to be appropriate without any restrictions for the purpose of hazard and risk assessment of barium sulfide.
Read-across to Ba(OH)2 and BaCl2, respectively:
Upon dissolution in water and/or physiological media, dissociation of barium sulfide to release Ba2+ions may initially be expected.
However, based on the established fact that barium ions may form poorly soluble species for example with physiologically present carbonate ions, the bioaccessibility/bioavailability may vary between different physiological conditions. Notwithstanding this limitation, it is considered justified to read-across from available data either on barium hydroxide (similar water solubility) and/or barium chloride (higher water solubility), the latter representing a conservative approach). In this context, the water solubility of a substance is used as a first approximation of bioavailability:
- barium chloride is highly water soluble with ca. 375 g/L at 20 °C/pH ca. 6.5 (510.4 g/L at pH 1.5)
- barium hydroxide is also highly water soluble (37.4 g/L at 20 °C/pH > 13).
In comparison, the water solubility of barium sulfide is 73.5 g/L at 20 °C (pH 13.7; saturated solution).
In conclusion, read across from barium chloride and barium hydroxide to barium sulfide is considered as justified since the toxicity of these substances may reasonably be considered to be determined by the availability of barium cations. It is noted that although BaS is a strong base, substantial neutralisation in the gastrointestinal tract at pH-levels of approx. 1.5 – 2 may nevertheless be anticipated.
Barium:
No relevant studies on neurotoxicity were found during literature search conducted with barium compounds.
Sulfides:
From mechanistic studies with intraperitoneal injection of sodium hydrogensulfide to rats it can be concluded that the lung and not the brain is the primary site of action of hydrogen sulfide, with an afferent neural signal from the lung via the vagus inducing apnea. In addition, substantial changes in neurotransmitter amino acids in the brainstem responsible for neuronal control of breathing were noted. Analyses of effects of sodium hydrogensulfide on brain transmitter systems and monoamine oxidase (MAO) activity after i.p. administration to rats led to the suggestion that inhibition of MAO may be an important contributing factor to the mechanisms underlying loss of respiratory drive after H2S exposure.
Mechanistic in-vitro and in-vivo studies with Na2S revealed that sulfide toxicity can be ascribed to the inhibition of cytochrome oxidase as key enzyme of the respiratory chain. Sodium sulfide has also been shown to strongly inhibit neuronal cytochrome oxidase and carbonic anhydrase causing disruption to respiratory and mitochondrial functions in the rat brain in vitro. Inhibitory effects on synaptosomal respiration and transmitter kinetics were shown after i.p. injection into rats with sodium sulfide.
In in-vivo studies with short-term exposures of rats to H2S, a cumulative effect on hippocampal EEG theta activity was observed at high exposure levels that required two weeks for a complete recovery. Neocortical EEG and Large Amplitude Irregular Activity (LIA) were unaffected. Furthermore, behavioural toxicity was observed in rats only at higher concentrations (≥80 ppm) of H2S. But, regional brain catecholamine levels or performance on the fixed-interval (FI) schedule were not affected. Perinatal exposure of pregnant rats to hydrogen sulfide resulted in alterations of serotonin and norepinephrine levels in the cerebellum and frontal cortex of the pups.
Justification for classification or non-classification
Based on mechanistic in-vitro and in-vivo (i.p.) studies with NaHS and Na2S, it is not possible to derive a no effect level or low effect level which is relevant for real exposure situations. This holds also true for the study with examination of effects on hippocampal EEG theta activity following short-term inhalation exposure of rats to H2S, because it cannot be ruled out that these changes are related to a sensory olfactory stimulation, and it is not known whether these changes are related to any adverse clinical effects. However, in short-term behavioural study in rats, some effects on motor activity were observed at high exposure levels. However, study duration was only 5 days, and it is likely that adaptation occurs after longer-term exposure durations, because no behavioural effects were observed in a 90-day inhalation toxicity study with H2S at the same exposure level. Although it was shown that perinatal exposure of pregnant rats to hydrogen sulfide resulted in alterations of serotonin and norepinephrine levels in the cerebellum and frontal cortex of pups, detailed behavioural tests in offspring of dams exposed by inhalation to H2S until gestation day 19 and dams and pups from postnatal day 5 to 18 revealed no clinical effects.
Therefore, it can be concluded that neurotoxicological effects of Na2S and NaHS could be demonstrated in-vitro and following i.p. injection, but subchronic inhalation exposure to H2S did not result in clinical effects of neurotoxicity in adult rats and their offspring.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.